Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data

Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data

Background/Aims Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid arthritis (RA), but safety concerns about malignancy remain. The aim of this study was to evaluate cancer risk in RA patients treated with TNF inhibitors (TNFi), based on Korean Nationwide Health Insur...

Full description

Bibliographic Details
Main Authors: Seung Min Jung, Seung-Ki Kwok, Ji Hyeon Ju, Yong-Beom Park, Sung-Hwan Park
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2019-05-01
Series:The Korean Journal of Internal Medicine
Subjects:
rheumatoid arthritis
tumor necrosis factor
tnf inhibitors
malignancy
cancer
Online Access:http://www.kjim.org/upload/pdf/kjim-2016-374.pdf

Similar Items

Similar Items